L. Leung, B. Linclau / Journal of Fluorine Chemistry 129 (2008) 986–990
989
serve as an alternative to existing methods that enables the facile
0.2 mmol) in dichloroethane (3.3 mL) at 70 8C for 16 h. The crude
was purified by column chromatography (EtOAc/petroleum ether
15 ! 30%) to afford a colourless oil (282 mg, 69%). 19F NMR
(282 MHz, CDCl3) ꢂ102.3 (d, J = 262.0 Hz), ꢂ107.0 (d, J = 262.0 Hz);
1H NMR (400 MHz, CDCl3) 4.36 (2H, q, J = 7.0 Hz), 4.23 (1H, dtd,
J = 9.0, 7.0, 4.5 Hz), 3.65 (2H, t, J = 6.5 Hz), 2.92 (1H, dtd, J = 18.5,
15.5, 6.5 Hz), 2.74 (1H, dddd, J = 18.0, 15.5, 12.5, 7.0 Hz), 1.87–1.69
and 1.61–1.29 (15H, m), 1.38 (3H, t, J = 7.0 Hz); 13C NMR (100 MHz,
CDCl3) 163.6 (t, J = 32.5 Hz), 115.3 (t, J = 251.5 Hz), 63.4, 63.1,
45.5 (t, J = 23.0 Hz), 32.9, 29.6, 29.4, 28.6, 25.8, 23.4 (t, J = 3.5 Hz),
14.3.
introduction of an
a,a-difluoroalkyl fragment.
4. Experimental
4.1. General experimental procedures
1H and 13C NMR spectra were recorded at room temperature on
a Bru¨ker DPX400 or AV300 spectrometer as indicated. Chemical
shifts are quoted in ppm relative to residual solvent peaks as
appropriate. Low resolution ES mass spectra and EIMS were
recorded on a Waters ZMD and Thermoquest TraceMS Quadrapole
spectrometer respectively. Infrared spectra were recorded as neat
films on a Nicolet Impact 380 ATR spectrometer. Melting points
were recorded on a Gallencamp Melting Point Apparatus and are
uncorrected.
4.2.3. Ethyl 2,2-difluoro-4-iodo-7-oxooctanoate (13) [9c]
Ester 13 was prepared from hex-5-en-2-one (118
mL,
1.0 mmol), difluoroacetate 1b (324 mg, 1.3 mmol) and AIBN
(49.2 mg, 0.3 mmol) in dichloroethane (3.3 mL) at 60 8C for 16 h.
The crude was purified by column chromatography (EtOAc/
petroleum ether 15:85) to afford a pink oil (216 mg, 60%) which
Column chromatography was performed on 230–400 mesh
Matrex silica gel. Preparative HPLC was carried out using a Biorad
needed to be stored in the freezer to minimise decomposition. 19
F
Biosil D 90-10, 250 mm ꢁ 22 mm column eluting at 20 mL minꢂ1
,
NMR (282 MHz, CDCl3) ꢂ102.4 (d, J = 264.5 Hz), ꢂ106.6 (d,
J = 264.5 Hz); 1H NMR (400 MHz, CDCl3) 4.30 (2H, q, J = 7.5 Hz),
4.21 (1H, dtd, J = 10.5, 7.0, 4.0 Hz), 2.89 (1H, dtd, J = 18.0, 15.5,
6.5 Hz), 2.77–2.54 (3H, m), 2.13 (3H, s), 2.05 (1H, dddd, J = 15.0, 8.5,
6.5, 4.0 Hz), 1.94 (1H, m), 1.33 (3H, t, J = 7.0 Hz); 13C NMR
(100 MHz, CDCl3) 206.5, 163.3 (t, J = 32.5 Hz), 115.0 (t,
J = 251.5 Hz), 63.3, 45.4 (t, J = 23.0 Hz), 43.5, 34.1, 30.1, 22.2, 13.9.
connected to a Kontron 475 refractive index detector. Reactions
were monitored by TLC (Merck) with detection by KMnO4 or
anisaldehyde stains.
Reaction solvents were dried before use as follows: THF and
Et2O were distilled from sodium/benzophenone; CH2Cl2 and Et3N
were distilled from CaH2; toluene was distilled from sodium. Ethyl
iododifluoroacetate (light pink) was purchased from Fluorochem
Ltd and in most cases was used without further purification. If the
purchased ethyl iododifluoroacetate was deep purple in colour, the
reagent was dissolved in Et2O, washed with sat. Na2S2O3 solution
and concentrated in vacuo to give a light yellow oil. Zinc metal was
activated by stirring with 1 M HCl and washed with H2O followed
by anhydrous THF. All reaction vessels were flame dried under
vacuum prior to use and all experiments were carried out under a
nitrogen atmosphere. All other reagents were purchased from
commercial sources and used without further purification.
4.2.4. Ethyl 2,2-difluoro-4-iodo-5-(1,3-dioxoisoindolin-2-
yl)pentanoate (14)
Ester 14 was prepared from N-allyl phthalimide (187 mg,
1.0 mmol), difluoroacetate 1b (324 mg, 1.3 mmol) and AIBN
(32.8 mg, 0.2 mmol) in dichloroethane (3.3 mL) at 70 8C for
16 h. The crude was purified by column chromatography
(EtOAc/petroleum ether 15:85) to afford
a colourless oil
(161 mg, 37%). IR (cmꢂ1) 2985 w, 1767 m, 1709 vs, 1614 w,
1468 w, 1430 m, 1392 s; 19F NMR (282 MHz, CDCl3) ꢂ102.1 (d,
J = 265.0 Hz), ꢂ106.2 (d, J = 264.0 Hz); 1H NMR (400 MHz, CDCl3)
7.90–7.86 (2H, m), 7.78–7.73 (2H, m), 4.59 (1H, m), 4.34 (2H, q,
J = 7.0 Hz), 4.14 (1H, dd, J = 14.5, 8.5 Hz), 3.97 (1H, dd, J = 14.5,
7.5 Hz), 2.94 (1H, dtd, J = 17.5, 16.0, 7.5 Hz), 2.79 (1H, dddd,
J = 17.5, 16.0, 13.0, 6.0 Hz), 1.36 (3H, t, J = 7.0 Hz); 13C NMR
(100 MHz, CDCl3) 168.1, 163.5 (t, J = 33.0 Hz), 134.8, 132.1, 124.1,
115.3 (t, J = 252.5 Hz), 63.8, 46.4, 43.2 (t, J = 23.5 Hz), 15.9 (m),
14.3; ES+ m/z (%) 460 ((M+Na)+, 90), 492 ((M+Na+MeOH)+, 100);
HRMS (ES+) for C15H14F2INO2 (M+H)+: Calcd 438.0008; Measured
438.0002.
4.2. Typical procedures forthe preparationof 2,2-difluoro-4-iodo esters
AIBN was added to a solution of alkene and iododifluoroacetate
1b in dichloroethane. The mixture was stirred at 70 8C for 16 h,
followed by concentration in vacuo. The crude mixture was
purified by column chromatography to afford the desired 2,2-
difluoro-4-iodo esters.
4.2.1. Ethyl 2,2-difluoro-4-iodohexadecanoate (11)
Ester 11 was prepared from tetradecene 4 (92% purity; 275
mL,
1.0 mmol), difluoroacetate 1b (374 mg, 1.5 mmol) and AIBN
(16.4 mg, 0.1 mmol) in dichloroethane (3.3 mL) at 70 8C for 16 h.
The crude was purified by column chromatography (EtOAc/
petroleum ether 0 ! 5%) to afford a colourless oil (395 mg, 88%).
IR (cmꢂ1) 2923 vs, 2853 s, 1770 vs, 1466 m, 1432 w, 1374 m,
1338 w, 1299 m, 1183 s, 1071 vs; 19F NMR (282 MHz, CDCl3) ꢂ102.3
(d, J = 263.0 Hz), ꢂ107.0 (d, J = 264.5 Hz); 1H NMR (400 MHz, CDCl3)
4.35 (2H, q, J = 7.0 Hz), 4.23 (1H, dtd, J = 8.5, 7.0, 4.5 Hz), 2.92 (1H,
dtd, J = 18.5, 16.0, 6.5 Hz), 2.74 (1H, dddd, J = 18.0, 16.0, 13.0, 7.5 Hz),
1.87–1.69 (2H, m), 1.59–1.21 (20H, m), 1.38 (3H, t, J = 7.0 Hz), 0.89
(3H, t, J = 7.0 Hz); 13C NMR (100 MHz, CDCl3) 163.6 (t, J = 32.0 Hz),
115.4 (t, J = 251.5 Hz), 63.4, 45.6 (t, J = 22.5 Hz), 32.1, 29.79, 29.76,
29.70, 29.66, 29.55, 29.51, 28.7, 23.5 (t, J = 4.0 Hz), 22.9, 14.3, 14.1;
ES+ m/z (%) 469 ((M+Na)+, 100); HRMS (ES+) for C18H33F2IO2
(M+Na)+: Calcd 469.1386; Measured 469.1378.
4.2.5. Ethyl 2,2-difluoro-4-iodo-4-(trimethylsilyl)butanoate (15) [9c]
Ester 15 was prepared from vinyltrimethylsilane (440
mL,
3.0 mmol), difluoroacetate 1b (249 mg, 1.0 mmol) and AIBN
(16.4 mg, 0.1 mmol) in dichloroethane (3.3 mL) at 70 8C for 16 h.
The crude was purified by column chromatography (EtOAc/
petroleum ether 0 ! 5%) to afford a colourless oil (302 mg, 86%).
19F NMR (282 MHz, CDCl3) ꢂ102.5 (d, J = 260.0 Hz), ꢂ108.0 (d,
J = 260.0 Hz); 1H NMR (400 MHz, CDCl3) 4.36 (2H, q, J = 7.0 Hz),
3.11 (1H, m), 2.68–2.58 (2H, m), 1.38 (3H, t, J = 7.0 Hz), 0.19 (9H, s);
13C NMR (100 MHz, CDCl3) 163.9 (t, J = 32.5 Hz), 115.8 (t,
J = 249.0 Hz), 63.3, 39.2 (t, J = 24.0 Hz), 14.0, 4.5, ꢂ2.3.
4.2.6. Ethyl 2,2-difluoro-2-(2-iodocyclohexyl)acetate (16) [9c,10a]
Ester 16 was prepared from cyclohexene (304
mL, 3.0 mmol),
difluoroacetate 1b (249 mg, 1.0 mmol) and AIBN (16.4 mg,
0.1 mmol) in dichloroethane (3.3 mL) at 70 8C for 16 h. The crude
was purified by column chromatography (EtOAc/petroleum ether
5 ! 20%) to afford a colourless oil (234 mg, 70%, cis/trans 1.0:2.1).
4.2.2. Ethyl 2,2-difluoro-5-hydroxy-4-iodododecanoate (12) [9c]
Ester 12 was prepared from 9-decen-1-ol (184
mL, 1.0 mmol),
difluoroacetate 1b (324 mg, 1.3 mmol) and AIBN (32.8 mg,